These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 22024394

  • 1. Progestogens and venous thromboembolism among postmenopausal women using hormone therapy.
    Canonico M, Plu-Bureau G, Scarabin PY.
    Maturitas; 2011 Dec; 70(4):354-60. PubMed ID: 22024394
    [Abstract] [Full Text] [Related]

  • 2. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
    Canonico M.
    Maturitas; 2015 Nov; 82(3):304-7. PubMed ID: 26276103
    [Abstract] [Full Text] [Related]

  • 3. Hormone therapy and venous thromboembolism among postmenopausal women.
    Scarabin PY.
    Front Horm Res; 2014 Nov; 43():21-32. PubMed ID: 24943295
    [Abstract] [Full Text] [Related]

  • 4. Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis.
    Scarabin PY.
    Climacteric; 2018 Aug; 21(4):341-345. PubMed ID: 29570359
    [Abstract] [Full Text] [Related]

  • 5. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
    Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY, Estrogen and Thromboembolism Risk (ESTHER) Study Group.
    Circulation; 2007 Feb 20; 115(7):840-5. PubMed ID: 17309934
    [Abstract] [Full Text] [Related]

  • 6. EMAS position statement: Managing menopausal women with a personal or family history of VTE.
    Tremollieres F, Brincat M, Erel CT, Gambacciani M, Lambrinoudaki I, Moen MH, Schenck-Gustafsson K, Vujovic S, Rozenberg S, Rees M, European Menopause and Andropause Society.
    Maturitas; 2011 Jun 20; 69(2):195-8. PubMed ID: 21489728
    [Abstract] [Full Text] [Related]

  • 7. Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.
    Olié V, Plu-Bureau G, Conard J, Horellou MH, Canonico M, Scarabin PY.
    Menopause; 2011 May 20; 18(5):488-93. PubMed ID: 21178641
    [Abstract] [Full Text] [Related]

  • 8. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
    Canonico M, Fournier A, Carcaillon L, Olié V, Plu-Bureau G, Oger E, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F, Scarabin PY.
    Arterioscler Thromb Vasc Biol; 2010 Feb 20; 30(2):340-5. PubMed ID: 19834106
    [Abstract] [Full Text] [Related]

  • 9. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.
    Scarabin PY, Hemker HC, Clément C, Soisson V, Alhenc-Gelas M.
    Menopause; 2011 Aug 20; 18(8):873-9. PubMed ID: 21487317
    [Abstract] [Full Text] [Related]

  • 10. Postmenopausal hormone therapy and venous thromboembolism.
    Olié V, Canonico M, Scarabin PY.
    Thromb Res; 2011 Feb 20; 127 Suppl 3():S26-9. PubMed ID: 21262434
    [Abstract] [Full Text] [Related]

  • 11. Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study.
    Bouaziz E, Canonico M, Verstuyft C, Carcaillon L, Martin F, Scarabin PY, Guiochon-Mantel A, EStrogen, THromboEmbolism Risk (ESTHER) Study Group.
    Maturitas; 2009 Oct 20; 64(2):136-8. PubMed ID: 19782484
    [Abstract] [Full Text] [Related]

  • 12. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
    Rovinski D, Ramos RB, Fighera TM, Casanova GK, Spritzer PM.
    Thromb Res; 2018 Aug 20; 168():83-95. PubMed ID: 29936403
    [Abstract] [Full Text] [Related]

  • 13. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF, Oger E.
    Climacteric; 2012 Jun 20; 15(3):235-40. PubMed ID: 22612609
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Postmenopausal hormone therapy and the risk of venous thromboembolism.
    Rachoń D, Teede H.
    Climacteric; 2008 Aug 20; 11(4):273-9. PubMed ID: 18645692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.